SHR-8068 Clinical Trials
8 recruitingDrug
Phase 27Phase 15Phase 31
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.876 enrolled1 locationNCT06703177
Recruiting
Phase 1Phase 2
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Recurrent or Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.100 enrolled1 locationNCT06859775
Recruiting
Phase 3
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.590 enrolled1 locationNCT06618664
Recruiting
Phase 1Phase 2
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
Non-small Cell Lung Cancer (NSCLC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.400 enrolled1 locationNCT06754930
Recruiting
Phase 2
A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.54 enrolled2 locationsNCT06778031
Recruiting
Phase 2
Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer
Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.80 enrolled1 locationNCT06465563
Recruiting
Phase 1Phase 2
A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.124 enrolled1 locationNCT06589778
Recruiting
Phase 1Phase 2
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.129 enrolled1 locationNCT05444088